VictoLabs

Victolabs is building an AI-native execution layer for life sciences companies, eliminating operational inefficiencies across regulatory affairs and pharmacovigilance. Today, regulatory and drug safety operations are fragmented across vendors, siloed systems, and document-heavy processes. Victolabs replaces this model with a unified platform where AI agents execute work directly across submissions, lifecycle management, case processing, signal detection, aggregate reporting, and literature monitoring. Instead of coordinating across multiple tools and service providers, teams operate within continuous, structured workflows where regulatory and safety functions run in parallel. From early development to post-market surveillance, data and processes remain connected removing duplication, reducing delays, and preserving full lifecycle context. The platform enables end-to-end execution, covering regulatory submissions and updates, ICSR processing, medical review, signal management, and periodic safety reporting within a single system built for consistency, traceability, and global compliance. Available as both SaaS and on-premise deployment, Victolabs integrates into existing environments while maintaining strict control over data, infrastructure, and compliance requirements. This model allows organizations to increase throughput, support more products, accelerate time-to-market, and scale regulatory and safety operations without increasing vendor dependency or headcount. Victolabs is not another layer on top of existing workflows. It is the system where regulatory and pharmacovigilance work is executed.